What sparked Dr. Berger’s interest in neuroradiology?
He was instrumental in developing a software program using PET to diagnose dementias, which later was licensed and became available commercially. Since then, he’s advised on the development of other similar programs using PET or MRI, has contributed as the lead clinical site for the validation of imaging software programs, and has assisted companies with obtaining regulatory clearance for their software programs to assess neurodegenerative diseases. As he said, he knows firsthand that “for imaging quantification software, the timeline from research application to clinical use can be long.”
Have quantitative imaging programs become more accepted by radiologists?
When can quantitative imaging assessments have the greatest impact?
What role does cMRI have in Dr. Berger’s practice?
The end goal is a more holistic approach to patient assessment.
We’re looking forward to continuing to work with Dr. Berger and benefit from his insights on radiology practice, imaging software, and more. If you’d like to learn more about cMRI, contact us for a discussion or a demo, or take advantage of our free 10-day trial of cMRI on your own patient cases.